Posts in tag

osteoarthritis


Debbie Rigby rounds up the latest in research news Regular use of proton pump inhibitors and risk of type 2 diabetes A prospective analysis over 200,000 participants shows an association …

In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …

A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …

Osteoarthritis (OA) is a leading cause of disability that affects more than 3 million Australians. At APP 2021, Professor David Hunter, Florance and Cope Chair of Rheumatology, Professor of Medicine, the University of Sydney spoke …

Supported by GSK Consumer Healthcare All modified release paracetamol products have now changed from Pharmacy Medicine (Schedule 2) to Pharmacist Only Medicine (Schedule 3). Former PSA president, John Bell discusses …

Supported by GSK Consumer Healthcare All modified release paracetamol products changed from Pharmacy Medicine (Schedule 2) to Pharmacist Only Medicine (Schedule 3). Former PSA president, John Bell discusses how this …

Debbie Rigby takes a look at the latest in research news  Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients With Atrial Fibrillation In this retrospective, cohort study …

Supported by GSK Consumer Healthcare All modified release paracetamol products have now changed from Schedule 2 to Schedule 3 medicine. Former PSA president, John Bell discusses what this means for pharmacists …

The way osteoarthritis (OA) is managed is evolving. The up-schedule of modified release (MR) paracetamol to Pharmacist Only (S3) on 1 June 2020 provides pharmacists with the opportunity to reassess …

Debbie Rigby rounds up the latest in research news Amiodarone in the aged Amiodarone is a highly effective antiarrhythmic drug, but can have serious adverse effects, particularly in older patients. …

Debbie Rigby takes a look at the latest in research news Safety of Proton Pump Inhibitors in patients receiving rivaroxaban or aspirin In a large placebo-controlled randomized trial, pantoprazole was …

Debbie Rigby takes a look at the latest in research news Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy In this population-based …